Contact and place of performance
Linda Smith
Bethesda, MD 20892
USA
Notice of Intent to Sole Source SAM.gov Draft Title: Notice of Intent to Sole Source – Expansion of HighRes Automated Plate Handling System for NCATS Notice ID: NIH-NOI-26-PCA-NCATS-06129 Notice Type: Special Notice / Notice of Intent to Sole Source Agency: Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Center for Advancing Translational Sciences (NCATS) Produ...
View moreDescription
This is a Notice of Intent to Sole Source and is not a request for competitive quotations. The National Institutes of Health (NIH), National Center for Advancing Translational Sciences (NCATS), intends to negotiate and award a sole source contract to:
HighRes Biosolutions
102 Cherry Hill Drive
Beverly, MA 01915
United States
for the Expansion of the HighRes Automated Plate Handling System for NCATS.
The statutory authority for this sole source acquisition is 41 U.S.C. 3304(a)(1), as implemented by FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements.
NCATS currently operates an existing HighRes automated laboratory plate handling system used to support high-throughput screening and translational research workflows. The purpose of this requirement is to expand the installed system to support increased screening capacity and improved management of specialized compound libraries.
The acquisition includes proprietary HighRes hardware, software, and services necessary to integrate additional capacity into the existing platform, including but not limited to:
The current platform was specifically designed as a proprietary, scalable HighRes system, and any expansion requires direct compatibility with its hardware architecture, control software, and integration framework. HighRes Biosolutions is the original manufacturer and integrator of the installed NCATS system and possesses the unique technical knowledge, proprietary parts, software, and integration capability required to perform this expansion.
Market research determined that while other vendors may offer laboratory automation and robotic plate handling systems, no other source can provide a fully compatible expansion to the existing HighRes platform without substantial risk of incompatibility, system disruption, redesign, reverse engineering, schedule delays, increased cost, and warranty invalidation.
The estimated value of this acquisition is $660,655.85.
This notice is for informational purposes only. However, any responsible source that believes it is capable of meeting the Government’s requirement may submit a capability statement. Capability statements must demonstrate the ability to provide all required proprietary hardware, software, integration, installation, testing, and validation services necessary to expand the existing HighRes system without compromising compatibility, performance, or warranty coverage.
Responses must be submitted in writing via email to the points of contact identified below no later than June 24, 2026 at 11:00am EST.
A determination by the Government not to compete this proposed acquisition based upon responses to this notice is solely within the discretion of the Government. Information received will be considered only for the purpose of determining whether to conduct a competitive procurement.
Place of Performance
National Center for Advancing Translational Sciences (NCATS)
9800 Medical Center Drive
Bethesda, MD 20850
Period of Performance
12 months from date of award
Instructions to Interested Parties
Interested parties may identify their interest and capability to respond to this requirement by submitting:
Responses shall be limited to 5 pages and submitted electronically to the points of contact below.
Primary Point of Contact
Linda Smith
[email protected]
Secondary Point of Contact
Danielle Tines
[email protected]
Disclaimer
This notice does not constitute a solicitation for offers, proposals, or quotations. The Government does not intend to award a contract on the basis of responses to this notice. No reimbursement will be made for any costs associated with providing information in response to this notice.
The National Institutes of Health (NIH), National Center for Advancing Translational Sciences (NCATS), issued this special notice of intent to award a sole source contract to HighRes Biosolutions for the expansion of an existing HighRes automated laboratory plate handling system. Located in Bethesda, Maryland, this project seeks to increase screening capacity and improve the management of specialized compound libraries for high-throughput screening and translational research. The acquisition, identified under solicitation number NIH-NOI-26-PCA-NCATS-06129, is categorized under NAICS code 339113, Surgical Appliance and Supplies Manufacturing, and PSC 6640, Laboratory Equipment and Supplies. There is no set-aside designated for this requirement.
The scope of work involves the delivery and integration of proprietary hardware and software, including a custom table system with an ACell robot, SteriStore D automated incubator, plate stackers, lid handling components, and orientation devices. The contractor will also provide Cellario software and device drivers, installation, commissioning, and user acceptance testing. HighRes Biosolutions is the original manufacturer and integrator of the installed NCATS system, possessing the proprietary technical knowledge and parts necessary to ensure hardware compatibility and integration without system disruption or warranty invalidation. The estimated value for this firm-fixed-price contract is $660,655.85, with a performance period of 12 months from the date of award.
The government intends to proceed with a sole source award scheduled for approximately August 14, 2026, citing that only one responsible source can satisfy the agency's requirements. While this is not a request for competitive quotations, responsible sources may submit a technical capability statement demonstrating their ability to provide the required OEM-compatible expansion and integration. Responses are due by June 24, 2026, at 11:00 AM EST, and must be submitted to the primary point of contact, Linda Smith. Documentation for this notice includes two attachments: a Notice of Intent (NOI.pdf) and a Bill of Materials (BOM.pdf).
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.